ALKBH5 and glioblastoma: ALKBH5 knockdown impaired VEGF-A secretion in both in vitro and in vivo settings in GBM cells, decreasing the pro-angiogenesis ability of GBM cells (Tao et al., 2022; Fan et al., 2024).